Testing for SARS-CoV-2 is a major public health priority worldwide. A clinical metagenomic approach to SARS-CoV-2 diagnosis provides the ability to enable molecular epidemiological studies and provide insight into viral dynamics in patients. Further refinements will allow increased sensitivity, and potentially a more robust approach than RT-PCR based approaches.
Benjamin Briggs MD, PhD, Kenneth Rand MD, Nicole Lovine MD, PhD, Kartik Cherabuddi, MD, Robert Schlaberg MD, PhD
Presented at Association for Molecular Pathology Annual Meeting, November 2020
Product: Explify Respiratory